DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Contribución de congreso (ConferenceOutput)
Design, synthesis and biological evaluation of peptidomimetic ureas analogues of the thrombin receptor PAR1 antagonist RWJ-58259
Trabajo presentado en el XVI Congress SEQT: From a classical to a new age in medicinal chemistry, celebrado en Valencia (España) del 18 al 21 de septiembre de 2011., Thrombin regulates multiple cellular responses, such as platelet aggregation and tumor cell proliferation and angiogenesis. These cellular effects of thrombin are mediated by the activation of the protease-activated receptor PAR1. This activation unveils at the N-terminal exodomain of PAR1 the tethered activation ligand SFLLRN. First potent PAR1 antagonists were SFLLRN-based peptidomimetic ureas, represented by RWJ-58259 (Figure), which was the first antagonist that provided in vivo proof of the clinical utility of PAR1 antagonists in cardiovascular and tumoral diseases. Taking into account these precedents and recent structural studies on the thrombin/PAR1 interaction,3 a small and directed library of RWJ-58259 analogue ureas of general formula 1 has been design, synthesized and screened as PAR1 antagonists., This work was supported by the Spanish Ministry of Science and Innovation grants SAF2006-01205 and SAF2009-09323. P. V.-A. holds a FPI fellowship from the Spanish Ministry of Science and Innovation.
Project:
MEC SAF2006-01205
,
MICINN SAF2009-09323
View at: http://hdl.handle.net/10261/336094